Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000887176 | SCV001030721 | likely benign | Maple syrup urine disease | 2024-10-28 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001273311 | SCV001456207 | uncertain significance | Maple syrup urine disease type 1A | 2020-01-24 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003948379 | SCV004764776 | likely benign | BCKDHA-related disorder | 2019-10-30 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |